Clinical trial
Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors
NCT00003711 · San Antonio Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003711 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors |
| Official title | A Phase I Trial of LY231514 With Irinotecan Administered Intravenously Every 21 Days in Patients With Metastatic Cancer |
| Lead sponsor | San Antonio Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride, pemetrexed disodium |
| Start date | Sep 1, 1997 |
| Completion | Sep 1, 2004 |
| First posted | Sep 14, 2004 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: